MEDIDEVS
Timeline
11 events since 2020Filings
Financial
Establishments
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 46 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0753600819
2025
Annual accounts 2024 filed PDFmicro format · 66 days before the deadline
2024
Liquidity more than doubled current ratio 6.43 The current ratio rises from 2.61 to 6.43. Short-term debt falls from €49,604 to €16,247.
Equity above €100,000 equity €105,002 ▲6.7% With a profit in every financial year since 2021, equity grows to €105,002.
Annual accounts 2023 filed PDFmicro format · 33 days before the deadline
2023
Highest result from 2021 to 2025 net €93,651 ▲93.8% The operating result of €125,484 and the net result of €93,651 are both a record.
Annual accounts 2022 filed PDFmicro format · on the deadline day
2022
Annual accounts 2021 filed PDFmicro format · 31 days late
2020
IncorporationFounding capital of €10,000, 100 shares · Founder: JOOSTENS Dirk Geert Jan (comparant oprichter) · Appointment: JOOSTENS Dirk Geert Jan (director) · published on 04-09-20205 points ▸
- Founder, JOOSTENS Dirk Geert Jan (comparant oprichter)
- Founding capital, €10,000, 100 shares
- Registered office clause, Sperwerlaan 6, 2280 Grobbendonk
- Board rule, 1
- Director appointment, JOOSTENS Dirk Geert Jan (director (not named in the articles))
- The deed holds 4 more points.
First establishment Sperwerlaan 6, Grobbendonk
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
MEDIDEVS was incorporated on 2 September 2020 as a private limited company by one natural person, with a starting capital of €10,000.12 JOOSTENS Dirk Geert Jan is director of the company, appointed by deed of 04-09-2020.2 Total assets rose from €53,043 in 2021 to €119,330 in 2025.3